Funding for this research was provided by:
Institute of Infection and Immunity (HAL – 15798)
Received: 6 June 2021
Accepted: 5 August 2021
First Online: 20 August 2021
: This study has been given conditional approval from the McGill University Health Centre Research Ethics Board (ABHN_Goals 2020-6202). This trial was registered on clinicaltrials.gov (NCT04345484). All participants will provide written informed consent. This is version 1 of the protocol (Date May 31, 2020). Trial sponsor: McGill University Health Centre.
: Not applicable.
: The authors declare that they have no competing interests.